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Abstract Members of the trefoil factor (TFF) family are
mucin-associated polypeptides that are expressed along the entire
length of the gastrointestinal tract. TFFs have been proposed to
play a role in mucosal defence through both protective and
reparative mechanisms. The potential relationship between TFFs
and mucins in non-gut glycoprotein-secreting epithelia has not
been fully explored. In the present study we identified TFF2 and
TFF3 mRNA and peptide in rat lymphoid tissues, demonstrated
that TFF peptide expression in rat spleen increased 1.5- to 3-fold
following experimental induction of the immune response, and
showed that hTFF2 and hTFF3 (1^5 mg/ml) stimulated
migration of human monocytes. Our data suggest that TFFs
may in part be involved in the repair of injury through the
modulation of the inflammatory response.
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1. Introduction
Trefoil factors (TFFs) comprise a group of small polypep-
tides that are characterised by one or more three-looped struc-
tural motifs resembling a three leaf clover or trefoil [1]. There
are three known mammalian members of the TFF family
called TFF1, 2, and 3.
Collectively, the trefoil peptides are expressed along the
entire length of the normal gastrointestinal tract, with TFF1
and TFF2 expressed primarily by the stomach [2^4], and
TFF3 by the intestine and colon [5^7]. The cellular sites of
trefoil expression are invariably associated with extensive gly-
coprotein biosynthesis and secretion, and trefoil expression
has been localised to mucus-secreting cells of the gastrointes-
tinal mucosa [2,4,5]. Both a structural [8] and functional [9^
11] association between mucus glycoproteins and the TFFs
have been proposed, and it is possible that this is of wide-
spread physiological importance.
While the precise role of the trefoil peptides is still largely
unknown, in vivo studies have shown that parenteral [12,13],
as well as oral [14,15] administration of TFFs protect the rat
gastric mucosa against NSAID-induced injury. This cytopro-
tective function is supported by the production of TFF trans-
genic animals in which loss of TFF1 or TFF3 leads to in-
creased susceptibility to damage [16,17], and over-expression
of TFF1 results in increased resistance to damage [18]. These
observations are also underscored in in vitro systems where
hTFF2 and rTFF3 were shown to act synergistically with
mucin glycoproteins to enhance protection of intestinal epi-
thelial cells against a variety of injurious agents [11]. A po-
tential role for the TFFs in the reparative process through
restitutive mechanisms is also inferred from observations dem-
onstrating that TFFs stimulate the migration of epithelial cells
in monolayer culture [10,12,13].
While it is likely that the TFFs major role is in the main-
tenance of gastrointestinal integrity, a potential relationship
between TFFs and non-gastrointestinal glycoprotein-secreting
tissues has not been fully explored. For instance, both endo-
thelial cells and leukocytes express glycoproteins that may be
de¢ned as mucins by virtue of their O-glycosylation patterns
and proline, serine and threonine rich domains [19]. These
molecules, such as CD34, CD43, glycosylation-dependent
cell adhesion molecule-1 (GlyCAM-1) and mucosal addressin
cellular adhesion molecule-1 (Mad-CAM-1), act as ligands for
the selectins and integrins and participate in the adhesion
cascade by which peripheral leukocytes tra⁄c to lymphoid
organs and/or in£amed tissue [20]. Since TFF3 has been
shown to regulate E-cadherin-catenin, and APC-catenin inter-
actions [21], it is possible that the trefoil factors may also
facilitate migration through an association with mucins in
these extra-gastrointestinal sites.In this study we have un-
equivocally identi¢ed the expression of the trefoil peptides
TFF2 and TFF3 in rat lymphoid tissues, shown that TFFs
can be induced in splenic tissue by the bacterial cell wall
endotoxin lipopolysaccharide, and demonstrated a potential
function for these peptides as stimulators of monocyte migra-
tion.
2. Materials and methods
2.1. Animals
Six male and four female Long Evans rats (250^310 g) were used to
investigate the distribution of trefoil factors in various tissues.
2.2. mRNA analysis
Total cellular RNA was prepared from 11 tissues by using the acid-
phenol method developed by Chomczynski and Sacchi [22].
2.2.1. Identi¢cation of TFF2 mRNA by RNase protection assay
(RPA). Antisense 32P-UTP (Bresatec, SA, Australia) labelled
TFF2 riboprobe (from Dr. G. Je¡rey) was incubated with 5^20 Wg
of total RNA and hybridised overnight at 45‡C, essentially as de-
scribed by Krieg and Melton [23], except that hybrids were digested
with 20 Wg/ml Rnase A and 1 Wg/ml Rnase T1 (Promega, Madison,
WI, USA) at 37‡C for 30 min. Protected fragments were resolved on
5% acrylamide/8 M urea gels, vacuum dried and laid against auto-
radiographic ¢lm for 7^18 days.
2.2.2. Identi¢cation of TFF2, TFF3 and GAPDH mRNA by RT-
PCR. RT: Four Wg of total RNA from rat stomach, intestine, thy-
mus, spleen, heart and liver was reverse transcribed with MMLVre-
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verse transcriptase (Gibco-BRL, Gaithersberg, MD, USA), after
which the product was denatured at 95‡C for 5 min and cooled on ice.
PCR: TFF2: A 519 bp fragment of the rat TFF2 sequence [3] was
ampli¢ed from single stranded DNA by PCR using two oligonucleo-
tide primers speci¢c for the rat TFF2 cDNA sequence. Sense primer
5P-GTCCAGTGGAGCAGACAT (nucleotides 14^31) and antisense
primer 5P-CACTGCTGAGGCTCAAGA (nucleotides 516^533; Gib-
co-BRL).
TFF3: A 422 bp fragment of the rat TFF3 sequence [7] was am-
pli¢ed from single stranded DNA by PCR using two oligonucleotide
primers speci¢c for the rat TFF3 cDNA sequence. Sense primer 5P-
GTACCTCGAGATGGAGACCAGAGCCTTCTG (nucleotides 18^
37) and antisense primer 5P-TCAGTCTAGAACAGCCTTGTGCT-
GACTGTA (nucleotides 401^420; Gibco-BRL). Bases underlined
are added enzyme restriction sites. The sense primer contains an
XhoI linker and the antisense primer contains an XbaI linker (under-
lined).
GAPDH: A 420 bp fragment of the rat GAPDH sequence [24] was
ampli¢ed from single stranded DNA by PCR using two oligonucleo-
tide primers speci¢c for the rat GAPDH cDNA sequence. Sense pri-
mer 5P-TGTCAGCAATGCATCCTGCACCACC (nucleotides 503^
527) and antisence primer 5P-GAAGTCACAGGAGACAACCTG-
GTCC (nucleotides 898^923; Bresatec).
Reagent conditions for PCR reactions were 5 Wl or 10 Wl of each
RT reaction, 50 ng of each primer, 10 mM Tris pH 8.3, 50 mM KCl,
2.0 mM MgCl, 200 WM dNTPs and 1.25 U of Taq DNA Polymerase
(Promega), in a total volume of 50 Wl. Each ampli¢cation consisted of
denaturing at 95‡C for 40 s, annealing at 45‡C (GAPDH) or 60‡C
(TFF2, TFF3) for 40 s, and polymerisation at 72‡C for 1 min. Twenty
¢ve (GAPDH) and 30 (TFF2, TFF3) cycles of ampli¢cation were
performed after kinetic analysis to ensure that DNA ampli¢cation
was in the linear range for each template. PCR products (15 Wl)
were resolved on 2% agarose gels.
2.3. Peptide analysis
Antibodies were raised in rabbits against a synthetic peptide com-
prising the C-terminal 10 amino acid sequence encoded by either the
rat TFF2 or TFF3 cDNA [25]. Rat tissues and the plasmacytoma cell
line HPC108.1 (from Dr. A. Harris, Walter and Eliza Hall Institute,
Australia) were extracted for TFF2 and TFF3 peptide analysis by
RIA and WBA according to methods previously described [26].
Immunohistochemistry was performed on consecutive serial section
of Bouin’s ¢xed rat spleen so that a comparison of the cellular ex-
pression of TFF2 and ED-1 (an established marker of macrophages,
monocytes and activated microglia) could be made. TFF2 immuno-
reactivity (ir) was assessed according to methods previously described
[26]. ED-1-ir was assessed by pre-incubation with 5% normal goat
serum for 30 min, followed by incubation with monoclonal anti-rat
ED-1 antisera (neat; from Dr. P. Tipping, Monash Medical Centre,
Australia) for 1 h. Sections were subsequently reacted with biotiny-
lated goat anti-mouse IgG secondary antibody (diluted 1:50 in 1%
BSA) for 30 min, followed by mouse peroxidase-anti-peroxidase (di-
luted 1:100 in 1% BSA) for 30 min, then DAB.
2.4. Temporal expression of TFF2 and TFF3 in the rat spleen following
LPS
In order to assess the e¡ect of lipopolysaccharide (LPS) on trefoil
expression, 32 male Long Evans rats were injected with 20 Wg of LPS
(Escherichia coli 127: B8 endotoxin; Difco, Detroit, MI, USA) i.p.
2 h^14 days before killing. Non-injected (0 h) rats were used as con-
trols. Upon killing, rat spleens were excised and analysed for TFF2
and TFF3 peptide expression by RIA according to methods previ-
ously described [26].
2.5. Stimulation of human monocyte migration by recombinant TFF2
and TFF3
Ten ml of fresh human blood was heparinised, layered onto 8 ml of
Ficoll-Paque and centrifuged at 1200 rpm for 30 min at 20‡C. The
mononuclear leukocyte rich layer was collected, washed three times in
Hanks bu¡ered salt solution (Trace Bioscienti¢c, Castle Hill, Austral-
ia) and resuspended in Dulbecco’s modi¢ed Eagle’s medium (DMEM,
Trace Bioscienti¢c) at 1U106 cells/ml.
Monocyte migration was assayed in a 48-well micro-chemotaxis
chamber (Neuro Probe Inc., Cabin John, MD, USA). The potential
migratory stimuli (glycosylated human TFF2 and human TFF3 at
concentrations of 0, 1, 2 and 5 mg/ml in DMEM), and a positive
control (0.5 mg/ml Zymosan A), were added to the lower wells of
the microchamber plate. A polycarbonate ¢lter with 5 Wm pores sep-
arated the lower wells from the upper wells. After the human mono-
nuclear leukocyte solution was added to the upper wells (50 Wl), the
entire chamber was incubated for 2 h at 37‡C in a humidi¢ed atmos-
phere with 5% CO2. Following incubation monocytes on the under-
side of the ¢lter were ¢xed in methanol and stained with haematox-
ylin. The number of cells that had migrated toward the putative
migratory factor were counted microscopically. Migratory activity
was expressed as the relative percentage of Zymosan A activity.
3. Results
3.1. Identi¢cation of TFF2 and TFF3 mRNA in rat spleen
RPA was used to examine the distribution of rat TFF2
Fig. 1. a: RNase protection assay of total RNA from adult rat tis-
sues (stomach 5 Wg, other tissues 20 Wg) hybridised with a rat TFF2
riboprobe (267 bp). The size of the free probe was 582 bp. Detect-
able levels of rat TFF2 mRNA were identi¢ed in spleen, intestine
and stomach. Exposure, 18 days at 370‡C. b: RTC-PCR analysis
of TFF2 mRNA, GAPDH mRNA, and TFF3 mRNA in adult rat
tissues. TFF2 mRNA was detected in the rat stomach, intestine,
thymus and spleen but not the heart or liver. Rat GAPDH mRNA
was detected in all tissues at similar levels. Rat TFF3 mRNA was
detected in the rat stomach, intestine, thymus and spleen. Control
reactions containing total RNA but without transcriptase demon-
strate that the products were not ampli¢ed due to primer contami-
nation.
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mRNA in adult rat tissues (Fig. 1). Protected fragments were
detected in rat stomach, intestine and spleen but not liver,
oesophagus, ovary, kidney, lung, heart or brain. Due to the
low concentration of TFF2 message in the rat intestine and
spleen, RT-PCR was used to produce enough cDNA for sub-
sequent analyses. Using speci¢c primers, we detected the pre-
dicted 519 bp TFF2 fragment in rat stomach, intestine, thy-
mus and spleen, but not in heart or liver (Fig. 1b). The level
of GAPDH was similar in all tissues (Fig. 1b), con¢rming the
speci¢city of the PCR conditions for TFF2 detection.
To determine the identity of the 519 bp fragments detected
in rat stomach, spleen and thymus, each ampli¢ed product
was subcloned and sequenced (data not shown). Without
exception, the sequences were the same in each tissue and
identical to the nucleotide sequence reported for rat TFF2
[3].
Given the sensitivity of RT-PCR, we chose this technique to
screen rat tissues for TFF3 expression. A 422 bp TFF3 am-
pli¢ed product was detected using speci¢c primers in rat stom-
ach, intestine, thymus and spleen (Fig. 1b).
3.2. Identi¢cation of TFF2 and TFF3 peptide in rat lymphoid
tissues
TFF2 peptide was detected by RIA in rat lymphoid tissues
at concentrations between 20% and 61% that of the fundic
region of the rat stomach (Fig. 2). TFF3 peptide was detected
by RIA in rat lymphoid tissues at concentrations between 4%
and 19% that of the rat intestine (Fig. 2).
Expression of TFF2 peptide (at V12 kDa) and the mono-
meric form of the TFF3 peptide (at V7 kDa) was con¢rmed
in the rat spleen by Western blot analysis (data not show-
n).Immunohistochemistry showed that TFF2-ir was present
in large splenic cells, with eccentrically placed, oval, spherical
or bilobed nuclei, characteristic of macrophage and/or B cells/
plasma cells (Fig. 3a). Expression of the macrophage marker
ED-1 was not co-localised with TFF2-ir in splenic white pulp
(Fig. 3b).
3.3. Temporal expression of TFF2 and TFF3 in rat spleen
following LPS (endotoxin) treatment
The time course of TFF2 and TFF3 peptide expression
following exposure to LPS was quanti¢ed by RIA. There
was a signi¢cant fall in TFF2-ir in rat spleen at 4 and 14 h
after LPS treatment compared to controls (55.3 þ 8.3% and
65.0 þ 6.2% of TFF2 basal levels, respectively; P6 0.05).
TFF2-ir increased signi¢cantly in the rat spleen at 96 h,
7 days and 14 days after LPS (132.5 þ 8.1%, 147.8 þ 10.7%
and 144.5 þ 10.3% of TFF2 basal levels, respectively;
P6 0.05; Fig. 4a). TFF3-ir increased 2^3-fold in rat spleen
between 14 h (181.7 þ 25.8% of TFF3 basal levels, P6 0.05)
and 14 days (251.2 þ 16.5% of TFF3 basal levels, P6 0.05)
post-LPS (Fig. 4a).
3.4. Recombinant hTFF2 and hTFF3 stimulate human
monocyte migration
Glycosylated recombinant human TFF2 and recombinant
human TFF3, at concentrations of 1, 2 and 5 mg/ml, were
evaluated for their ability to recruit human monocytes. Cell
migration in DMEM alone was 2.0 þ 0.2% that of the activity
of Zymosan A and this dose dependently increased to
4.7 þ 0.9% (1 mg/ml), 16.0 þ 6.1% (2 mg/ml) and 27.5 þ 7.1%
(5 mg/ml) after treatment with TFF2 (Fig. 4b). TFF3 also
Fig. 2. TFF2 and TFF3 peptide expression in rat lymphoid tissues
by RIA. TFF2 (E) and TFF3 (F) peptide was detected in stomach,
spleen, thymus, lymph nodes and bone marrow and the plasmacyto-
ma cell line HPC108.1, but not in brain or heart where levels fell
below the sensitivity of the assay.
Fig. 3. Immunohistochemical localisation of a: TFF2 and b: ED-1 in consecutive sections of the rat spleen. TFF2 was localised to large cells
with eccentric nuclei located mainly in the periphery of the white pulp (arrows). These cells lacked ED-1 immunoreactivity. Counterstained
with haematoxylin (U1000).
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increased monocyte migration to 16.0 þ 6.8% (1 mg/ml),
22.9 þ 8.4% (2 mg/ml) and 30.0 þ 11.8% (5 mg/ml) that of
Zymosan A-induced activity. All doses of TFF2 and TFF3
produced signi¢cantly greater activity than media alone
(P6 0.05).
4. Discussion
The cellular sites of TFF expression in the gut are mainly
associated with extensive glycoprotein biosynthesis and secre-
tion, and TFFs have been localised by both immunohisto-
chemistry and in situ hybridisation to mucus-secreting cells
[2,4,5]. While exploring the expression of trefoils in other
non-neoplastic mucin glycoprotein-secreting tissues, such as
the lung, ovary and lymphoid organs, TFF2 and TFF3
mRNAs were detected in the rat spleen and thymus. While
a previous study by Hirota et al. reported TFF1 mRNA in
mouse spleen [27], this is the ¢rst study to unequivocally dem-
onstrate TFF2 and 3 gene expression by rodent lymphoid
tissues. Subsequent experiments revealed that both these pep-
tides were also expressed by other lymphoid tissues including
lymph nodes and bone marrow.
Trefoil peptide immunoreactivity has been localised to a
small number of unidenti¢ed cells in rat spleen and thymus.
These cells were negative for the macrophage marker ED-1,
but displayed cellular morphology characteristic of plasma
cells. Both TFF2 and TFF3 have been detected by region-
speci¢c RIA in the plasmacytoma HPC108.1, however the
lack of a speci¢c immunohistochemical marker for rat plasma
cells has so far precluded the unequivocal localisation of the
trefoil peptides to this cell type.
What is the normal function of the trefoil peptides in the
spleen and other lymphoid organs? One possible implication
from our data showing trefoil peptide expression by tissue
plasma cells is that these peptides act in concert with secreted
immunoglobulins. This is plausible since most immunoglobu-
lins, like mucins, are variably glycosylated. However, in un-
published studies using the sensitive technique of plasmon
resonance spectroscopy to detect weak interactions, we have
been unable to show a direct binding interaction between
recombinant TFF2 or TFF3 and IgG or IgA.
An alternative explanation may be that trefoil peptides aid
in the immune response by regulating leukocyte recruitment at
sites of severe epithelial damage and bacterial invasion. Evi-
dence that trefoil peptides stimulate cell migration [10,12,13]
and modulate epithelial cell adhesion and migration through
regulation of the APC-catenin and E-cadherin-catenin com-
plexes [21], together with the studies in this paper demonstrat-
ing that trefoils stimulate monocyte migration at concentra-
tions similar to those found in gastrointestinal secretions [3],
suggests that these peptides are capable of playing a role in
regulating leucocyte migration in vivo. This might be accom-
plished directly, of by an interaction with one or more of the
cell surface mucins which participate in the regulation of leu-
kocyte adhesion to the endothelium.
Migration of various leukocyte subpopulations from the
bloodstream into in£amed tissues or recirculation into lym-
phoid tissues is controlled by adhesion receptors and chemo-
attractants which direct them to the site of injury. The selec-
tins and integrins are among the ¢rst adhesion molecules
acting in this process. They aid in the docking of leukocytes
to endothelial cell surfaces and participate in leukocyte roll-
ing. GlyCAM-1, CD34 and MAdCAM-1 are sialomucins
which contain large clusters of O-linked carbohydrate side
chains, and which are expressed on the apical membrane of
endothelial cells where they act as ligands for L-selectin (Gly-
CAM-1 and CD34) and the integrin alpha 4 beta 7 (Mad-
CAM-1), and initiate weak tethering of leukocytes to the en-
dothelium [28]. Whether or not the trefoils interact with these
mucin glycoproteins to facilitate leukocyte migration and ad-
hesion remains to be elucidated, and is the focus of ongoing
investigation. However, the fact that trefoil peptides are ac-
tively secreted after synthesis [29] and their expression is up-
regulated several-fold by bacterial wall LPS, is consistent with
such a role in the in£ammatory response. Whatever their
physiological role, we have shown that the trefoil peptides
TFF2 and 3 are expressed by the main organs involved in
immune regulation, that they can be induced by bacterial
endotoxin, and are able to stimulate monocyte migration.
Together, these observations suggest a potential role for the
trefoil peptides in the immunological response to tissue injury.
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Fig. 4. a: Time course of expression of TFF2 (E) and TFF3 (F) in
rat spleen following LPS administration. Each bar represents the
mean þ S.E.M. of four rats. (*P6 0.05, t-test). b: Stimulation of mi-
gration of human monocytes (% Zymosan A) by media alone
(striped bar), glycosylated human TFF2 (E) and human TFF3 (F).
Each treatment was run in triplicate. Bars denote mean þ S.E.M. for
¢ve separate experiments. (*P6 0.05, t-test).
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